Free Trial

Establishment Labs (ESTA) Competitors

Establishment Labs logo
$41.23 -1.25 (-2.94%)
Closing price 04:00 PM Eastern
Extended Trading
$41.28 +0.05 (+0.12%)
As of 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ESTA vs. SLNO, IRTC, INSP, TMDX, NVST, PRCT, WRBY, LIVN, EYE, and LMAT

Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

Establishment Labs vs. Its Competitors

Establishment Labs (NASDAQ:ESTA) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

In the previous week, Soleno Therapeutics had 1 more articles in the media than Establishment Labs. MarketBeat recorded 9 mentions for Soleno Therapeutics and 8 mentions for Establishment Labs. Soleno Therapeutics' average media sentiment score of 1.34 beat Establishment Labs' score of 0.78 indicating that Soleno Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Soleno Therapeutics
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 6.4% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Establishment Labs has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$166.02M7.18-$84.60M-$3.10-13.30
Soleno TherapeuticsN/AN/A-$175.85M-$4.62-18.18

Soleno Therapeutics has a net margin of 0.00% compared to Establishment Labs' net margin of -52.34%. Soleno Therapeutics' return on equity of -77.52% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-52.34% -196.25% -26.64%
Soleno Therapeutics N/A -77.52%-63.44%

Establishment Labs has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.63, indicating that its share price is 363% less volatile than the S&P 500.

Establishment Labs currently has a consensus target price of $54.83, suggesting a potential upside of 32.99%. Soleno Therapeutics has a consensus target price of $108.70, suggesting a potential upside of 29.45%. Given Establishment Labs' higher probable upside, research analysts plainly believe Establishment Labs is more favorable than Soleno Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Soleno Therapeutics
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.09

Summary

Establishment Labs and Soleno Therapeutics tied by winning 8 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESTA vs. The Competition

MetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.23B$7.31B$5.70B$9.56B
Dividend YieldN/A2.82%4.71%4.06%
P/E Ratio-13.3024.5928.1919.94
Price / Sales7.1835.42461.9396.03
Price / CashN/A26.9436.3258.72
Price / Book21.708.858.295.77
Net Income-$84.60M$239.96M$3.25B$259.21M
7 Day Performance-5.15%-3.29%0.21%-0.80%
1 Month Performance0.73%1.88%8.71%9.81%
1 Year Performance-12.39%10.48%32.76%14.37%

Establishment Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESTA
Establishment Labs
2.1028 of 5 stars
$41.23
-2.9%
$54.83
+33.0%
-11.9%$1.23B$166.02M-13.301,018Analyst Upgrade
SLNO
Soleno Therapeutics
4.3452 of 5 stars
$86.97
-0.3%
$108.70
+25.0%
+75.8%$4.39BN/A-18.8230Positive News
Analyst Upgrade
IRTC
iRhythm Technologies
1.0084 of 5 stars
$135.52
-0.5%
$137.30
+1.3%
+55.2%$4.35B$591.84M-43.162,000Upcoming Earnings
INSP
Inspire Medical Systems
4.8593 of 5 stars
$125.13
-1.3%
$210.27
+68.0%
+3.9%$3.74B$802.80M57.661,246Positive News
Upcoming Earnings
Analyst Downgrade
TMDX
TransMedics Group
1.895 of 5 stars
$103.61
-5.7%
$129.88
+25.3%
-25.1%$3.72B$441.54M76.18210Positive News
Upcoming Earnings
NVST
Envista
3.3461 of 5 stars
$19.47
-0.2%
$20.23
+3.9%
+27.1%$3.31B$2.51B-2.9812,300Positive News
Upcoming Earnings
Analyst Forecast
PRCT
PROCEPT BioRobotics
2.6918 of 5 stars
$57.05
-2.2%
$84.13
+47.5%
-12.6%$3.23B$224.50M-33.56430Upcoming Earnings
WRBY
Warby Parker
2.8961 of 5 stars
$24.35
+1.7%
$22.88
-6.0%
+45.9%$2.50B$771.32M-202.903,780
LIVN
LivaNova
3.2836 of 5 stars
$42.35
+0.9%
$59.29
+40.0%
-18.9%$2.29B$1.25B-10.352,900Positive News
EYE
National Vision
2.6448 of 5 stars
$25.31
+0.9%
$22.10
-12.7%
+70.0%$1.98B$1.82B-76.6913,411Analyst Downgrade
LMAT
LeMaitre Vascular
2.2308 of 5 stars
$79.82
+0.1%
$97.83
+22.6%
-3.9%$1.80B$219.86M40.31490Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:ESTA) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners